To evaluate the NOD model as a potential predictor of CIT-associated risks for autoimmunity, we treated NOD mice with a murine anti–PD-1 as previously described (17) and integrated a longitudinal microbiota analysis as a novel component (Fig. 1A). The gene discussed is PDCD1; the disease is Autoimmunity.